A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
Keros Therapeutics, Inc.
Keros Therapeutics, Inc.
Case Comprehensive Cancer Center
University of Nebraska
Lynk Pharmaceuticals Co., Ltd
Ascentage Pharma Group Inc.
Medigene AG
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
Novartis
Northwestern University
M.D. Anderson Cancer Center
City of Hope Medical Center
Washington University School of Medicine
Northwestern University
Shandong University
Rutgers, The State University of New Jersey
Mayo Clinic
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
Roswell Park Cancer Institute
M.D. Anderson Cancer Center